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There is evidence for functional speciﬁcity of subregions along the rostrocaudal axis of the anterior
cingulate cortex (ACC). The subregion-speciﬁc distribution of dopaminergic afferents and glutamatergic
efferents along theACCmake these obvious candidates for coding such regional responses.We investigated
this possibility usingmicrodialysis in freely-moving rats to compare changes in extracellular dopamine and
glutamate in the rostral (‘rACC’: Cg1andCg3 (prelimbic area)) andcaudal (‘cACC’: Cg1 andCg2)ACC induced
by systemic or local administration of d-amphetamine. Systemic administration of d-amphetamine (3mg/
kg, i.p.) caused a transient increase in extracellular dopamine in the rACC, but an apparent increase in the
cACC of the same animals was less clearly deﬁned. Local infusion of d-amphetamine increased dopamine
efﬂux in the rACC, only. Glutamate efﬂux in the rACC was increased by local infusion of dopamine (5
e50 mM), which had negligible effect in the cACC, but only systemic administration of d-amphetamine
increased glutamate efﬂux andonly in the cACC. The asymmetry in the neurochemical responseswithin the
rACC and cACC, to the same experimental challenges, could help explain why different subregions are
recruited in the response to speciﬁc environmental and somatosensory stimuli and should be taken into
account when studying the regulation of neurotransmission in the ACC.
This article is part of the Special Issue entitled ‘CNS Stimulants’.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
The anterior cingulate cortex (ACC) lies within the medial pre-
frontal cortex (mPFC), which has a key role in governing cognition
and associated behaviours. The existence of subdivisions of the ACC
along its rostro-caudal axis is inferred from detailed cytochemistry
(Jones et al., 2005 (rat); Vogt, 2005 (primate)), including mapping
of its afferent inputs and efferent projections (Zeng and Stuesse,
1991, 1993; Devinsky et al., 1995; Heidbreder and Groenewegen,nin); ACC, anterior cingulate
teroposterior; Cg1, cingulate
Cg3; DV, dorsoventral; ECD,
lutamate transporter 1; ML,
noradrenaline; rACC, rostral
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r Ltd. This is an open access articl2003; Hoover and Vertes, 2007; Shibata and Naito, 2008). Func-
tional speciﬁcity of these subregions has been conﬁrmed in rodent
lesion studies, human neuroimaging (Milad et al., 2007) and
following brain trauma. For instance, there is a consensus that
different subregions of the ACC process different aspects of pain
sensation: whereas attention/perception seem to be processed in
caudal regions in the rat, affective aspects of pain sensation are
coded more rostrally (Devinsky et al., 1995; Bush et al., 2000;
Johansen et al., 2001; Vogt, 2005). Characterisation of differences
in neurotransmission in these subregions is important because they
have been implicated in a range of disorders, including: Attention
Deﬁcit Hyperactivity Disorder (Bush et al., 1999), increased risk of
psychosis (Fornito et al., 2008) andmethamphetamine dependence
(Paulus et al., 2003).
It has been suggested that there are reciprocal interactions be-
tween rostral and caudal zones of the ACC (Bush et al., 2000). This
was borne out in studies that further suggest that reciprocal
antagonism (‘anticorrelation’) between these zones extends to the
subcortical brain regions to which each projects (Margulies et al.,
2007; Fan et al., 2008). To date, there have been no comparisonse under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
Fig. 1. Typical locations of microdialysis probes (indicated by black lines) in the rACC
(ventral Cg1 and prelimbic cortex) and cACC (Cg1 and Cg2) regions of the anterior
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explain such functional reciprocity.
There is a strong rationale for predicting that dopaminergic
transmission, at least, will vary along the ACC. The dopaminergic
innervation of the ACC is strikingly heterogeneous. The density of
dopaminergic terminals is characteristically highest within Cg3
(now known as the prelimbic cortex) and declines in a caudal di-
rection (van Eden et al., 1987). The Cg1/Cg2 regions of the ACC are
innervated by dopaminergic neurones from both the A10 and A9
nuclei, but their distribution differs in superﬁcial (mainly A9) and
deep layers (mainly A10). By contrast, the prelimbic region is
innervated by neurones projecting from A10, only (Emson and
Koob, 1978; Lindvall et al., 1978; Swanson, 1982; Berger et al.,
1985; Zeng and Stuesse, 1991). These two groups of neurones
differ in a number of respects, such as: the extent of their collat-
eralisation (Loughlin and Fallon, 1984), expression of dopamine
transporters (greater in Cg1 than in Cg2 and prelimbic cortex: Freed
et al., 1995; Sesack et al., 1998) and co-storage of neurotensin
(Febvret et al., 1991).
As regards glutamate, it is well established that this trans-
mitter inﬂuences dopamine release in the prefrontal cortex and
elsewhere in the brain (PFC: e.g., Feenstra et al., 1995; Del Arco
and Mora, 2005). However, little is known about modulation of
glutamate release by dopamine within the ACC. Yet, this interac-
tion could have important functional consequences because
dopaminergic terminals converge on cortical pyramidal cells,
which are the conduit for cortical output. Dopamine also modu-
lates pyramidal cell activity and glutamate release indirectly
through interactions with both cortical GABA interneurons and
glutamatergic neurones that project from subcortical regions,
such as the thalamus and amygdala, to pyramidal cells in the
prefrontal cortex (Berger et al., 1991; Seamans and Yang, 2004).
The net effects of all these processes will have important conse-
quences for cognition and behaviour because pyramidal cells in
different zones of the ACC project to different subcortical brain
regions in a series of cortico-subcortical circuits (Koski and Paus,
2000; Heidbreder and Groenewegen, 2003; Jones et al., 2005;
Bissiere et al., 2008).
As a ﬁrst step in characterising any differences in neurotrans-
mission in subregions of the ACC that could underlie their func-
tional reciprocity and speciﬁcity, we used in vivo microdialysis to
compare changes in extracellular dopamine and glutamate (and
their interaction) in a rostral and caudal region of the ACC following
an acute d-amphetamine challenge. We chose this (pharmacolog-
ical) stimulus because d-amphetamine increases the extracellular
concentration of both dopamine and glutamate in the ACC and yet
there has been no systematic investigation of the extent to which
these responses generalise throughout its length.
The amount of dopamine and glutamate harvested by micro-
dialysis probes (‘efﬂux’) was monitored in a rostral zone (rACC:
spanning ventral Cg1 and the prelimbic (Cg3) area) and/or a caudal
zone (cACC: incorporating the ventral zone of Cg1 and Cg2) of the
ACC. These subregions are deﬁned according to nomenclature in
Paxinos and Watson (2005): but see Uylings et al., 2003) and were
chosen because they are reported to differ functionally: in rats, the
rACC is recruited in the response to glutamate-dependent condi-
tioned avoidance learning, whereas the cACC responds to uncon-
ditioned noxious stimuli (Johansen et al., 2001).
Findings from this study point to striking differences in the
regulation of dopaminergic and glutamatergic neurotransmission
in the rACC and cACC. These differences echo reports of functional
reciprocity between these subregions (Margulies et al., 2007) and
could help govern their respective roles in cognition and affective
behaviour.2. Materials and methods
All procedures were carried out under the licensed authority of the UK Animals
(Scientiﬁc Procedures) Act, 1986, and were approved by the local ethics committee
at University College London.2.1. Subjects and surgery
Male outbred SpragueeDawley rats (250e300 g) were obtained from the colony
at University College London. They were housed in groups of four, with sawdust
bedding, at 21 1 C and 55  1% relative humidity, with a lightedark cycle of 12 h
(lights on at 08.00 h) and free access to standard laboratory chow and water.
Anaesthesia was induced by inhalation of 5% halothane in 95% O2/5% CO2, delivered
at 2 L/min. Following loss of the righting reﬂex, rats were transferred to a stereotaxic
frame and anaesthesia maintained via a face mask (2e2.5% halothane in 95% O2/5%
CO2 at 1 L/min). The head was set in the ﬂat-skull position (incisor bar set at 3.3 mm
below the interaural line) using blunt ear-bars. Core temperature was maintained at
37 C using a homeothermic heating pad and rectal probe.
A small incision was made in the skin covering the skull. After trepanation,
microdialysis probes, primed with modiﬁed Ringer’s solution (NaCl, 145 mM; KCl,
4 mM; CaCl2, 1.3 mM), were implanted either uni- or contralaterally (for single or
dual-probe microdialysis, respectively) with the tip at the following co-ordinates
(mm from Bregma): (rACC) AP þ2.5, ML 0.6, DV 4.6; (cACC) AP þ1.0 ML 0.6,
DV -3.6 (Fig. 1, Paxinos and Watson, 2005). All probes were constructed in-house
from Hospal (AN 69) dialysis membrane (see: Dalley and Stanford, 1995) and were
equipped with a dialysis window that extended 2 mm above the end of the probe.
After anchoring the shaft of the probe(s) to the skull with acrylic cement, the rats
were allowed to recover from the anaesthesia, with lignocaine local anaesthetic
cover, in an incubation chamber, before transfer to individual plastic cages. On the
following day, the inlet and outlet tubes were guided through a liquid swivel, to
enable the rat to move freely around the cage, and the probes perfused with the
modiﬁed Ringer’s solution at a rate of 2 mL/min. Dialysis samples (40 mL) were
collected every 20 min and experiments were started after a minimum of three
successive samples conﬁrmed stable (baseline) transmitter efﬂux. In experiments
studying the response to local infusion of d-amphetamine or dopamine, different
microsyringes were used to deliver each of the test solutions. To minimise any
spontaneous degradation of the solutes, they were loaded onto the syringe pump
immediately before use and connected to the inﬂow for themicrodialysis probewith
minimal disturbance to the animal. At the end of each experiment, the animals were
deeply anaesthetised and killed by cervical dislocation. Brains were removed and
stored overnight in formalin solution for veriﬁcation of probe placement.2.2. Experimental protocols
Experiment 1: Probes were implanted contralaterally for simultaneous micro-
dialysis of the rACC and the cACC. The next day, spontaneous (basal) efﬂux of dopa-
mine was monitored in both subregions until it had stabilised, after which three basal
samples were designated T40-T0. At T0, rats were randomly assigned to groups given
either d-amphetamine (3 mg/kg, i.p), or saline (1 mL/kg): these two treatments were
administered in a counterbalanced sequence. This dose of d-amphetamine was cho-
sen because it is known to increase dopamine efﬂux without inducing stereotypy
(Segal and Mandell, 1974) and is within the range of those used typically to study its
effects on dopaminergic transmission (e.g., Goodwin et al., 2009).cingulate cortex (adapted from Paxinos and Watson, 2005).
Fig. 2. Effect of systemic administration of d-amphetamine (‘d-AMP’, 3 mg/kg, i.p) or
saline (1 mL/kg) on dopamine (‘DA’) efﬂux in the rACC or cACC of freely-moving rats.
Animals were injected at T0, indicated by the arrow. DA efﬂux is expressed as fmol/
20 min. Points show mean  s.e. mean. N ¼ 4-6 in each group. Statistical analysis was
carried out on Log(10) transformed data and revealed an increase in DA efﬂux in both
subregions between T20 and T140. *: P < 0.05 (c.f., d-amphetamine/saline) over the
time-period indicated by the bar. þ: P < 0.05 c.f., time-matched samples from the two
groups (T40eT0) for the bins indicated by the bar.
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infusion of d-amphetamine into the rACC and cACC, via the microdialysis probe
(10 mM d-amphetamine for 2 h, followed by modiﬁed Ringer’s solution for 1 h,
and then 100 mM d-amphetamine for 2 h). These concentrations were used
because they increase dopamine efﬂux in other brain regions (e.g., Mazei et al.,
2002) and they are within the range of (or lower than) those used in similar
published studies in vivo (Ventura et al., 2004; Géranton et al., 2003a, 2003b;
Abercrombie and De Boer, 1997 and further references cited therein). It should
be borne in mind that the concentration of d-amphetamine in the extracellular
ﬂuid will be maximum immediately adjacent to the probe but will fall progres-
sively as distance from the probe increases. As a consequence, the concentration
of d-amphetamine within the aura of the probe will span not only those used
routinely to study its actions in vitro (e.g., Piﬂ et al., 1995; Del Arco et al., 1998;
Bosse et al., 2008) but also the concentrations found typically in human plasma
in pharmacokinetic studies of this drug (Westerink and De Vries, 2001; Asghar
et al., 2003; Jasinski and Krishnan, 2009).
Experiment 2: Microdialysis probes were implanted in either the rACC or the
cACC of pairs of rats to compare glutamate efﬂux in the two subregions following a
d-amphetamine challenge. The rats were then randomly assigned to one of two test
groups. One was given d-amphetamine by systemic injection (3 mg/kg i.p.) at T0.
This dose is the same as that in Experiment 1 and has been reported to increase
glutamate efﬂux in the rostral zone of themedial prefrontal cortex (Reid et al., 1997).
The second group experienced local infusion of d-amphetamine: 1 mM (80 min),
followed by 10 mM (80 min) and then 100 mM (160 min).
Experiment 3: Probes were implanted on contralateral sides of the brain for
dual-probe microdialysis of the rACC and the cACC. The probes were used both to
harvest extracellular glutamate and for local infusion of dopamine. The stock
dopamine solution was kept on ice, in the dark, until loading into syringes for
simultaneous infusion into both the rACC and cACC. The test concentrations of
dopamine (0.05, 0.5, 5 and then 50 mM (80 min each)) were similar to those used
previously (Pan et al., 2004). There was no correction for spontaneous degradation
of dopamine, which would be the same for both regions.
2.3. Chromatography
Immediately after collection of the microdialysis samples, glutamate (which was
analysed after precolumn derivatisation with 20 mL of complete o-phthalaldehyde re-
agent (Rowley et al., 1995)) and dopamine were separated by HPLC and measured by
electrochemical detection (ECD) using an ESA Coulochem II detector. Both HPLC sys-
tems incorporatedanAquapore (7mM)guard columnbutdifferentmain columns (both
maintained at 26 C) were used to separate dopamine (Hypersil ODS; 5 mM;
250 4.6mm) andglutamate (SupercosilLC-18; 5mM;150 4.6mm). Forglutamate,
the mobile phase comprised (mM): Na2HPO4 64, NaH2PO4 16, EDTA 0.13, dissolved in
25% methanol, adjusted to pH 6.5 with phosphoric acid and pumped through the
system at 1 ml/min. The conditioning electrode of the microdialysis cell (ESA 5014A)
was set at 280 mV and the analytical electrode set at þ350 mV. For dopamine, the
mobile phase comprised (mM): NaH2PO4 83, octanesulphonic acid (OSA) 0.23, EDTA
0.84, dissolved in 17% methanol, adjusted to pH 4.0 with orthophosphoric acid and
pumped through the system at 1.15 ml/min. The conditioning electrode of the micro-
dialysis cell (ESA 5014A)was again set at280mVbut the analytical electrodewas set
at þ180 mV. The yield of solutes is expressed as fmol/20 min (dopamine) or pmol/
20min (glutamate), with no adjustment for probe recovery. The limit of detectionwas
1 pmol (glutamate) and 2e4 fmol (dopamine). In two rats, the dopamine content of
some baseline samples was below the limit of detection and was assigned a value of
0 fmol/20 min: both were from the group serving as saline-injected controls for the
effects of systemic administration of d-amphetamine on dopamine efﬂux in the rACC
(Experiment 1). Since there was no dopamine response in these animals, this will not
affect the interpretation of the results. There were no animals with basal DA levels
below the limit of detection in the local infusion experiments.
2.4. Statistical analysis
For each animal, mean basal efﬂux was calculated from the three consecutive
samples taken immediately before the experimental challenge. These data were
pooled to provide a measure of mean basal efﬂux for each experimental group. The
signiﬁcance of differences in transmitter efﬂux was assessed using multi-factorial
split-plot ANOVA (SPSS PC) with repeated measures on the factor, ‘time’. ANOVA
was carried out on the raw data unless the Mauchly test indicated statistically sig-
niﬁcant deviation from homogeneity of the variance/covariance matrix on the
repeated measures factor (time). In those cases, ANOVA was carried out on log(10)
transformed data, provided this reduced statistical signiﬁcance in the Mauchly test.
When signiﬁcance in this test remained, despite the transformation, the Green-
house-Geisser ε correction was applied to the degrees of freedom. The Levene’s test
was applied to ensure equal variances across all levels of the between subjects’
factors in the log(10)transformed data set. In all cases, a signiﬁcant effect on the main
factor(s), or interactions between them, was taken as the criterion for progressing to
a post-hoc 2-way ANOVA. In experiments testing the effects of systemic drug
administration, the data were divided into clusters (‘bins’) of consecutive samples.
The bins comprised 3 samples (i.e., 1 h of sampling time) in order to assess the
signiﬁcance of any changes in transmitter efﬂux. In experiments involving localinfusion of d-amphetamine or dopamine, the bins corresponded to samples
collected during infusion of each test concentration (i.e., 80min). In these cases, only
the last 3 samples in each binwere compared with the 3 basal samples and ‘bin’ was
treated as another within-subjects’ factor in the ANOVA. ‘Subregion’ was treated as a
‘between-subjects’ factor in single-probemicrodialysis and a ‘within-subjects’ factor
in the dual-probe experiments. The criterion for signiﬁcance was P  0.05.
2.5. Drugs and reagents
d-Amphetamine sulphate and dopamine hydrochloride were obtained from
SigmaeAldrich (UK). When given by intraperitoneal injection, the drug was dis-
solved in 0.9% sterile saline and administered in a volume of 1 mL/kg. When infused
locally into the terminal ﬁeld, d-amphetamine was dissolved in the modiﬁed
Ringer’s perfusion solution. All reagents for the modiﬁed Ringer’s solution and
mobile phase were of chromatographic or AnalaR grade.
3. Results
There was an increase in locomotor activity after systemic in-
jection of d-amphetamine but not during its local infusion. We saw
no sign of behavioural stereotypy in either case.
3.1. Experiment 1: the dopamine response to d-amphetamine
depends on subregion of the ACC and the route of drug
administration
There was no difference in mean basal efﬂux of dopamine in
the rACC [4.4  0.4 fmol/20 min] and cACC [5.7  0.8 fmol/20 min]
of animals destined for intraperitoneal injection of saline or d-
amphetamine (3 mg/kg). Saline injection did not affect dopamine
efﬂux in either region (Fig. 2). Dopamine efﬂux increased in the
Fig. 4. Glutamate (‘GLU’) efﬂux (A) following systemic administration of d-amphet-
amine (‘d-AMP’: 3 mg/kg, i.p) at T0 (indicated by arrow) (N ¼ 10). For analysis, data
were divided into 6 time bins of 3 samples, as indicated. Points show mean  s.e.
mean. *: P < 0.05 (cACC: d-AMP c.f. basal samples in Bin 1) (B) during local infusion (via
retrodialysis) of d-amphetamine at the concentrations and times indicated (N ¼ 7).
GLU efﬂux is expressed as pmol/20 min. Points show mean  s.e. mean.
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within 20 min of d-amphetamine administration, reached a
maximum of 27  8 fmol/20 min at T40, and lasted for approxi-
mately 2 h [c.f. d-amphetamine/saline (T20eT140): F(1,9) ¼ 5.8;
P ¼ 0.04; ε ¼ 0.45]. This increase was also evident when efﬂux
after drug administration was compared with the basal samples
[1st hour: F(1,4) ¼ 10.4, P < 0.03; 2nd hour: F(1,3) ¼ 10.0,
P < 0.05]. In the cACC of the same animals, the increase in
dopamine efﬂux also reached criterion for statistical signiﬁcance
when compared with the saline group [T20eT140: F(1,7) ¼ 10.3;
P ¼ 0.015; ε ¼ 0.344]. However, unlike the rACC, the increase in
dopamine efﬂux did not reach criterion for statistical signiﬁcance
when compared with the basal samples. The response to d-
amphetamine in the cACC was also more erratic than in the rACC,
but there was no difference in dopamine efﬂux in the two sub-
regions within this time-frame [F(1,16 ¼ 1.384; P ¼ 0.257] and no
interaction between drug treatment and subregion [T20eT140:
F(1,16) ¼ 0.025; P ¼ 0.88] (Fig. 2).
In a second cohort of rats, destined for local infusion of
d-amphetamine, the mean basal efﬂux of dopamine in the rACC
[14.3  2.4 fmol/20 min] was greater than in the cACC
[6.4  1.4 fmol/20 min] [F(1,11) ¼ 7.69; P ¼ 0.02] (Fig. 3). The
dopamine response depended strongly on subregion such that,
during infusion of d-amphetamine, overall dopamine efﬂux was
greater in the rACC than the cACC [F(1,17) ¼ 15,67; P < 0.001;
ε ¼ 0.623]. Speciﬁcally, infusion of the lower concentration of d-
amphetamine (10 mM) increased dopamine efﬂux in the rACC but
not the cACC [c.f., rACC and cACC; T20eT120: F(1,10) ¼ 9.53;
P ¼ 0.012; ε ¼ 0.55] (Fig. 3). Dopamine efﬂux returned to basal
levels when the modiﬁed Ringer’s perfusion solution was rein-
stated. When the higher concentration of d-amphetamine was
substituted for the modiﬁed Ringer’s solution (100 mM), there was a
resurgence of dopamine efﬂux in the rACC, which reached
maximum at T260 [63  21 fmol/20 min]. Again, dopamine efﬂux in
the rACC was greater than in the cACC [c.f., rACC and cACC; T200e
T300: F(1,7) ¼ 8.94; P ¼ 0.02; ε ¼ 0.36]. The apparent increase in the
cACC at the higher concentration of d-amphetamine did not meet
the criterion for statistical signiﬁcance [c.f., T20eT120 and T200eT300;
F(1,8) ¼ 2.44; P ¼ 0.11; ε ¼ 0.47] (Fig. 3).Fig. 3. Dopamine (DA) efﬂux during local infusion (via retrodialysis) of d-amphet-
amine (‘d-AMP’) into the rACC or cACC of freely-moving rats. d-Amphetamine was
infused from T0eT120 (10 mM) and from T180eT300 (100 mM) (indicated). R ¼ Ringer’s
solution. N ¼ 7. DA efﬂux is expressed as fmol/20 min. Points show mean value  s.e.
mean. *: P < 0.05 (rACC: c.f., cACC) for the period indicated by the bar. Both concen-
trations of d-amphetamine increased dopamine efﬂux in the rACC but not the cACC.3.2. Experiment 2: the glutamate response to d-amphetamine
depends on subregion of the ACC and route of drug administration
Mean basal efﬂux of glutamate in the rACC and cACC was
10.41.8 pmol/20min and 9.11.7 pmol/20min, respectively, and
did not differ in animals destined for intraperitoneal injection or
local infusion of d-amphetamine.
Following systemic administration of d-amphetamine (3 mg/kg,
i.p.), there was no statistical interaction between subregion and
glutamate response (Fig. 4A). Nevertheless, it is striking that
glutamate efﬂux in the rACC seemed to oscillate more than that in
the cACC and, when compared with the basal samples, did not
reach the criterion for statistical signiﬁcance at any time. By
contrast, in the cACC, therewas a robust andmore stable increase in
glutamate efﬂux within the ﬁrst hour post-injection [c.f., T40eT80
(bin 2) and the basal samples (T-40eT0): F(1,16) ¼ 6.21; P ¼ 0.024;
ε ¼ 0.929]. The maximum increase occurred at T80 [þ11.1 7 pmol/
20 min]. Apart from the samples collected from T160eT200 [(bin 4):
c.f., basal samples: F(1,17) ¼ 4.34; P < 0.08; ε ¼ 0.777], efﬂux
remained greater than that in the basal samples for the remainder
of the experiment [c.f., bin and the basal samples; T100eT140 (bin 3):
F(1,17) ¼ 6.554; P < 0.02; ε ¼ 0.756; T220eT260 (bin 5):
F(1,18) ¼ 6.06; P< 0.02; ε ¼ 0.659; T280eT320 (bin 6): F(1,17)¼ 6.85;
P < 0.018; ε ¼ 0.537] (Fig 4A).
Local infusion of d-amphetamine did not increase glutamate
efﬂux in either subregion. The apparent increase in glutamate
efﬂux into the rACC during infusion of 100 mM d-amphetamine
[T260eT320], was not statistically signiﬁcant when compared with
either the basal samples or across the two regions (Fig. 4B) (even
after removal of an outlier (>(3  standard deviations) from
mean).
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efﬂux in the rACC but not the cACC
Local infusion of dopamine increased glutamate efﬂux in the
rACC but not the cACC. Over the entire series of samples, an
interaction between concentration of dopamine infusion and brain
region just missed criterion for statistical signiﬁcance [F(1,17) ¼
4.19; P ¼ 0.056; ε ¼ 0.28]. However, efﬂux in the rACC during
infusion with 50 mM dopamine was greater than in time-matched
samples from the cACC [F(1,22) ¼ 4.41; P ¼ 0.048; ε ¼ 0.926] and
the response to 5 mM dopamine in the rACC just missed the crite-
rion for signiﬁcance [5 mM DA: F(1,25) ¼ 3.91, P < 0.059; ε ¼ 0.883]
(Fig. 5).4. Discussion
The results of this study reveal striking differences in dopami-
nergic and glutamatergic responses in the rACC and the cACC
following a d-amphetamine challenge.
The ﬁrst experiments used dual-probe microdialysis to monitor
dopamine efﬂux, simultaneously, in these two subregions. Either
systemic administration or local infusion of d-amphetamine pro-
duced a prominent dopamine response in the rACC. Systemic
administration, but not local infusion of d-amphetamine, also caused
amarginal increase indopamineefﬂux in thecACC. It ispossible thata
higher concentrationof locald-amphetaminewouldhaveprovoked a
dopamine response in the cACC. However, the key ﬁnding from these
experiments was that local administration of d-amphetamine had
negligible effects on dopamine efﬂux in the cACC at concentrations
that were effective in the rACC of the same animals.
Several factors could contribute to the more resilient response
to d-amphetamine in the rACC (see also: Pehek, 1999), notably
when administered locally. One is the greater density of dopami-
nergic terminals, especially in the prelimbic region (van Eden
et al., 1987). Another is the relatively low density of dopamine
transporters in the prelimbic region, compared with other regions
of the prefrontal cortex (see: Sesack et al., 1998 (and references
cited therein); Mundorf et al., 2001). This would constrainFig. 5. Effects of local infusion of dopamine (‘DA’) via retrodialysis, at the concentra-
tions (mM) and times indicated, on glutamate (‘GLU’) efﬂux in the rACC and the cACC of
freely-moving rats. Dopamine infusion started at T0. GLU efﬂux is expressed as pmol/
20 min. Points show mean value  s.e. mean. N ¼ 12e14. For statistical analysis, the
data were divided into 5 time-bins of 3 samples. The ﬁrst samples of each bin, taken
20 min after the change in perfusion solution, were not included in the analysis.
*: P < 0.05, [*]:P ¼ 0.059 c.f., time-matched samples in the two brain regions.dopamine clearance, which is a major determinant of the con-
centration of extracellular transmitter (Smith and Justice, 1994;
Géranton et al., 2003a). Moreover, accumulation of extracellular
dopamine will be augmented by d-amphetamine because this
compound is a substrate for translocation by the dopamine
transporter, and so a competitive inhibitor of dopamine uptake, as
well as a dopamine releasing-agent (at high concentrations). There
is also evidence that dopamine transporters in the prelimbic cor-
tex are concentrated in intervaricose regions of the nerve terminal
(Sesack et al., 1998), which would further reduce clearance efﬁ-
ciency and increase the amount of dopamine harvested by the
microdialysis probe. Given the evidence for ectopic uptake of
dopamine by noradrenaline transporters in the superﬁcial medial
prefrontal cortex (Cass and Gerhardt, 1995), another possible
explanation is that this process is more vigorous in the cACC than
the rACC. Also, somatodendritic (inhibitory) autoreceptors on
neurones projecting from the substantia nigra (A9), which could
be activated directly or indirectly (via polysynaptic loops), have a
greater inhibitory inﬂuence on neuronal ﬁring-rate than those in
the ventral tegmental nucleus (A10) (Cragg and Greenﬁeld, 1997).
This range of mechanisms, which would inﬂuence the concen-
tration of extracellular dopamine after treatment with d-
amphetamine, all tend to increase dopamine efﬂux in the rACC but
to constrain it in the cACC.
Regional variation in the dopamine response to d-amphetamine
could also rest on differences in factors such as: terminal hetero-
ceptors that govern dopamine release in the anterior cingulate
cortex (Gobert et al., 1998); the dimensions of the synaptic space;
tortuosity of the extrasynaptic space; uptake by the organic cation
transporter 3 (Gasser et al., 2009). Region-speciﬁc inhibition of
impulse-evoked dopamine release, mediated by glutamatergic
neurones, is also possible. For instance, glutamatergic inﬂuences on
dopaminergic neurones within the ventral tegmental nucleus can
either augment or inhibit impulse-dependent dopamine release in
the terminal ﬁeld; this process has been proposed to underlie
functional heterogeneity of dopaminergic projections to different
brain regions (Takahata and Moghaddam, 1998; see also: Del Arco
and Mora, 2009). Differences in any of these disparate pharmaco-
kinetic and pharmacodynamic inﬂuences on transmitter efﬂux
could account for the greater d-amphetamine-induced increase in
dopamine efﬂux in the rACC, compared with the cACC, even in the
absence of a difference in basal efﬂux.
These empirical observations prompted us to investigate
whether the net effect of all these processes has any bearing on
glutamatergic transmission within these subregions. The effect of
d-amphetamine on glutamate efﬂux, like dopamine, depended on
subregion of the ACC. Once again, route of administration was an
important factor, also. Clearly, we cannot assume that the concen-
tration of extracellular d-amphetamine in the ACC in these studies
was the same after its systemic administration and local infusion.
Nevertheless, our ﬁndings indicate that although systemic admin-
istration of d-amphetamine at this dose (3 mg/kg) caused a clear
increase in glutamate efﬂux in the cACC, this was not the case for
the rACC.
So far, no study has compared directly the glutamate response to
the same experimental challenge in different zones of the ros-
trocaudal axis of the ACC. We cannot distinguish whether the
response to systemic drug treatment, alone, accounts for the
regional difference in the glutamate response or whether a
response to drug injection is a contributing factor. Nevertheless, the
key ﬁnding is that the glutamate response to local infusion of
dopamine or systemic administration of d-amphetamine differs in
the two subregions. These ﬁndings are supported by published
evidence to the extent that glutamate efﬂux in the rACC is not
E.S. Ash et al. / Neuropharmacology 87 (2014) 180e187 185increased by systemic administration of d-amphetamine (c.f.,
AP: þ3.2; Shoblock et al., 2003).
The explanation for these regional differences in the glutamate
response is unclear, not least because there are several possible
sources of glutamate release from neurones in the ACC. These
include: dendrites of cortical pyramidal cells; terminals of cortico-
cortical pyramidal collaterals; and glutamatergic afferents from
subcortical regions (thalamocortical and amygdala) that converge
on somatodendritic regions of cortical pyramidal cells, which,
together with the terminals of dopaminergic afferents from A9 and
A10 nuclei, form neuronal ‘triads’ (Berger et al., 1991). Also, as
discussed later, glial cells are thought to serve as the prominent
source of glutamate harvested by microdialysis probes.
Both dopamine D1-like receptors and, to a lesser extent, D2-like
receptors are expressed by pyramidal cells. The density of these
receptor subtypes varies with cortical subregion but is compara-
tively high in the prelimbic region. It is now generally agreed that
these receptors have no consistent effect on pyramidal cell func-
tion: in electrophysiological studies in vitro, the pyramidal cell
response to activation of dopamine receptors is time- and
concentration-dependent; it can be mediated both directly and
indirectly; and depends on pyramidal cell excitable state (see:
Seamans and Yang, 2004; Santana et al., 2009). Nevertheless,
obvious questions that arise from our ﬁndings are whether dopa-
minergic transmission augments glutamate efﬂux in the rACC but
has little, if any, effect in the cACC, andwhether this has any bearing
on the different glutamate responses to d-amphetamine in the two
subregions.
On the basis that the increase in glutamate efﬂuxon local infusion
of dopamine was conﬁned to the rACC, it is unlikely that dopami-
nergic transmission within the cACC mediates the glutamate
response to systemic administration of d-amphetamine. However, d-
amphetamine also evokes release of noradrenaline and serotonin,
which could be alternative candidates for mediating the glutamate
response. Noradrenaline is likely to be of greater importance because
the density of noradrenergic terminals in the prelimbic cortex is
higher than in other cingulate areas (Morrison et al., 1979). Also, the
concentration of extracellular noradrenaline is increased in the rACC
by both local and systemic administration of d-amphetamine
(Géranton et al., 2003b). By contrast, d-amphetamine causes a rela-
tively small increase in serotonin release (Pum et al., 2007) and
neither systemic injection nor local infusion of the serotonin
releasing-agent, dexfenﬂuramine, increases extracellular glutamate
in the rostral frontal cortex (Rocher et al., 1996).
However, the lack of any glutamate response to local infusion of
d-amphetamine or dopamine within the cACC suggests that the
increase in glutamate efﬂux in this region, following systemic
administration of d-amphetamine, must recruit processes beyond
the aura of the probe. These could include distant neurones within
the cACC (i.e., terminals of collaterals from remote ipsilateral/
contralateral cortical pyramidal cells) but polysynaptic links are
possible, also, such as indirect activation of glutamatergic thala-
mocortical neurones.
It is important to bear in mind that glial cells (microglia and
astrocytes) are a prominent source of extracellular glutamate,
which is extruded on a glial cystine/glutamate antiporter (Baker
et al., 2002). This source of glutamate could be particularly
important in our experiments in view of evidence that glutamate
harvested by microdialysis probes, is non-synaptic in origin
(Timmerman and Westerink, 1997; van der Zeyden et al., 2008).
Glial cells also display Ca2þ-dependent exocytosis of glutamate
(Montana et al., 2006; reviewed by Malarkey and Parpura, 2008).
Given that astrocytes can be activated by dopamine (Reuss and
Unsicker, 2001) and inﬂuence the activity of neighbouring neuro-
nes, they could have a key role in the regulation and integration ofACC function (Del Arco et al., 2003; Zhang and Haydon, 2005;
reviewed by Fillenz, 2005). Indeed, d-amphetamine and dopamine
are already known to induce glial cell activation in the striatum
(Thomas et al., 2004) and extrusion of glutamate on the glial
transporter, GLT-1, in the ventral tegmental area (Wolf et al., 2000).
We are currently investigating the possibility that the difference in
d-amphetamine-evoked glutamate efﬂux in the rACC and cACC
involves glial cell activation and/or glutamate clearance on GLT-1
transporters.
In summary, this study has revealed a marked asymmetry in the
dopaminergic and glutamatergic responses within the rACC and
the cACC following an acute d-amphetamine or dopamine chal-
lenge. Such regional disparities should be taken into account in
electrophysiological and neurochemical studies of the ACC in vivo
and in vitro. Moreover, these contrasting responses could
contribute to the ‘functional reciprocity’ of subregions of the ACC
(e.g., Margulies et al., 2007), enabling them to make different con-
tributions to the regulation of mood and behaviour.Sources of support
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